These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Histopathological features of the terminal ileum in lymphocytic and collagenous colitis: a study of 32 cases and review of literature. Padmanabhan V; Callas PW; Li SC; Trainer TD Mod Pathol; 2003 Feb; 16(2):115-9. PubMed ID: 12591963 [TBL] [Abstract][Full Text] [Related]
11. [Ticlopidine, diarrhea and lymphocytic colitis]. Swine C; Cornette P; Van Pee D; Delos M; Melange M Gastroenterol Clin Biol; 1998 Apr; 22(4):475-6. PubMed ID: 9762283 [No Abstract] [Full Text] [Related]
12. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study. Boccalon H; Causse C; Yubero L Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028 [TBL] [Abstract][Full Text] [Related]
13. [Lymphocytic colitis caused by Cyclo 3 Fort]. Bouaniche M; Chassagne P; Landrin I; Kadri N; Doucet J; Bercoff E Rev Med Interne; 1996; 17(9):776-8. PubMed ID: 8959138 [No Abstract] [Full Text] [Related]
16. [Incidence and prognosis of collagenous and lymphocytic colitis]. Mühlhöfer A; Gross M; Zoller WG Z Gastroenterol; 1999 Dec; 37(12):1205-7. PubMed ID: 10666845 [No Abstract] [Full Text] [Related]
19. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. Beltramino R; Penenory A; Buceta AM Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525 [TBL] [Abstract][Full Text] [Related]